Current Pipeline
We develop and sustain a robust portfolio of valuable products that address the unmet medical needs of patients.
We develop multifunctional antibody derivatives applicable in various fields such as immune-oncology and infectious diseases. Baiya Phytopharm currently employs a Plug ‘n’ Play strategy across three of its research and development (R&D) initiatives: PlantamAb™ (Ab derived from plant), Fuseplanta™ (Ab fusion proteins), and Multiplanta™ (multispecific Ab). This strategy involves the generation of novel drug molecules targeting diverse disease mechanisms.
